Ichiko Kinjyo MD PhD, is a Research Assistant Professor of Molecular Medicine at the University of New Mexico and Comprehensive Cancer Center. She obtained her medical degree from Kagoshi-ma University (Japan) and completed 2 years-clinical training at Okinawa Prefectural Chubu Hospi-tal. She received a fellowship from the Japanese government to complete a PhD in Molecular Cel-lular Immunology at Kyushu University (Japan), with research about the immune regulation by sup-pressors of cytokine signaling (SOCS) family under the mentorship of Dr. Akihiko Yoshimura. She pursued postdoctoral training in the laboratory of Dr. Steven L Reiner at the University of Pennsyl-vania, where she learned T cell immunology through the research about T cell fate determination. After rejoining Dr. Yoshimura’s lab at Keio University (Japan), she conducted additional postdoctor-al research about the cell cycle progression during CD8 T cell differentiation in Dr. Wolfgang We-ninger’s lab at the University of Sydney. In 2013, she moved back to the USA and joined Dr. Bridget S Wilson’s lab at the University of New Mexico in Albuquerque and studied the immunotoxin-based treatment against acute lymphoblastic leukemia and determined the novel mechanisms for leuke-mia metastasis into the central nervous system. In 2017, she started to work with an excellent OB/GYN clinical researcher; Dr. Sarah F Adams MD, PhD, to extend the benefits of the novel combination treatment with PARP-inhibitors and immune checkpoint blockade in patients with ovari-an cancer. Her continuous interests in T cell biology have been inspired her toward cancer immu-notherapy to reactivate anti-tumor T cells against ovarian cancers.